Viewing Study NCT04138056


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-02 @ 10:11 PM
Study NCT ID: NCT04138056
Status: COMPLETED
Last Update Posted: 2024-08-21
First Post: 2019-10-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-11-05
Start Date Type: ACTUAL
Primary Completion Date: 2020-02-25
Primary Completion Date Type: ACTUAL
Completion Date: 2021-11-22
Completion Date Type: ACTUAL
First Submit Date: 2019-10-22
First Submit QC Date: None
Study First Post Date: 2019-10-24
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-11-18
Results First Submit QC Date: None
Results First Post Date: 2022-12-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2021-02-09
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-07-29
Last Update Post Date: 2024-08-21
Last Update Post Date Type: ACTUAL